JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502571200 on May 3, 2005

J. Biol. Chem., Vol. 280, Issue 26, 24915-24922, July 1, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/26/24915    most recent
M502571200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arima, K.
Right arrow Articles by Izuhara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arima, K.
Right arrow Articles by Izuhara, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of the Interaction between Interleukin-13 and Interleukin-13 Receptors*

Kazuhiko Arima{ddagger}, Kazuo Sato§, Go Tanaka{ddagger}, Sachiko Kanaji{ddagger}, Tohru Terada§||, Eijiro Honjo**, Ryota Kuroki**, Yo Matsuo§, and Kenji Izuhara{ddagger}{ddagger}{ddagger}§§

From the {ddagger}Division of Medical Biochemistry, Department of Biomolecular Sciences, and the {ddagger}{ddagger}Division of Medical Research, Center for Comprehensive Community Medicine, Saga Medical School, Saga 849-8501, the §Computational Proteomics Team, Protein Research Group, RIKEN Genomic Sciences Center, Yokohama 230-0045, the Graduate School of Integrated Sciences, Yokohama City University, Yokohama 230-0045, the ||Graduate School of Agricultural and Life Sciences, Faculty of Agriculture, The University of Tokyo, Tokyo 113-8657, and the **Structural Biology Group, Neutron Science Research Center, Japan Atomic Energy Research Institute, Ibaraki 319-1195, Japan

Interleukin-13 (IL-13) possesses two types of receptor: the heterodimer, composed of the IL-13R{alpha}1 chain (IL-13R{alpha}1) and the IL-4R{alpha} chain (IL-4R{alpha}), transducing the IL-13 signals; and the IL-13R{alpha}2 chain (IL-13R{alpha}2), acting as a nonsignaling "decoy" receptor. Extracellular portions of both IL-13R{alpha}1 and IL-13R{alpha}2 are composed of three fibronectin type III domains, D1, D2, and D3, of which the last two comprise the cytokine receptor homology modules (CRHs), a common structure of the class I cytokine receptor superfamily. Thus far, there has been no information about the critical amino acids of the CRHs or the role of the D1 domains of IL-13R{alpha}1 and IL-13R{alpha}2 in binding to IL-13. In this study, we first built the homology modeling of the IL-13·hIL-13 receptor complexes and then predicted the amino acids involved in binding to IL-13. By incorporating mutations into these amino acids, we identified Tyr-207, Asp-271, Tyr-315, and Asp-318 in the CRH of human IL-13R{alpha}2, and Leu-319 and Tyr-321 in the CRH of human IL-13R{alpha}1, as critical residues for binding to IL-13. Tyr-315 in IL-13R{alpha}2 and Leu-319 in IL-13R{alpha}1 are positionally conserved hydrophobic amino acid residues. Furthermore, by using D1 domain-deleted mutants, we found that the D1 domain is needed for the expression of IL-13R{alpha}2, but not IL-13R{alpha}1, and that the D1 domain of IL-13R{alpha}1 is important for binding to IL-13, but not to IL-4. These results provide the basis for a precise understanding of the interaction between IL-13 and its receptors.


Received for publication, March 8, 2005 , and in revised form, April 21, 2005.

* This work was supported in part by a research grant for immunology, allergy, and organ transplant from the Ministry of Health, Welfare, and Labor of Japan, a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, and a grant from Mitsubishi Pharma Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§§ To whom correspondence should be addressed: Division of Medical Biochemistry, Dept. of Biomolecular Sciences, Saga Medical School, Saga 849-8501, Japan. E-mail: kizuhara{at}med.saga-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
C. Ratthe, M. Pelletier, S. Chiasson, and D. Girard
Molecular mechanisms involved in interleukin-4-induced human neutrophils: expression and regulation of suppressor of cytokine signaling
J. Leukoc. Biol., May 1, 2007; 81(5): 1287 - 1296.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.